Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education (CE)
Amedco is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This course is co-provided by Amedco and the American Association for the Study of Liver Diseases (AASLD) with a maximum of 12.25 contact hours. In addition to continuing nursing education, the following presentations are also eligible for 4.0 pharmacotherapeutic hours:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 12.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC points.
Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Tuesday, June 5, 2018. A link to the CME evaluation will be emailed to attendees after the meeting.
Participants must complete an evaluation form to receive a certificate of completion by Tuesday, June 5, 2018. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. A link to the CE evaluation will be emailed to attendees after the meeting.
Physicians seeking ABIM and/or ABP MOC points must complete the CME and MOC evaluation by Tuesday, June 5, 2018. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation.
MOC Points will be reported to the ABIM and ABP by the end of June 2018 for attendees who successfully complete the MOC evaluation.
The goal of the 2018 Clinical Hepatology Update Conference is to allow medical professionals the opportunity to review up-to-date diagnosis and management of a variety of liver diseases with experts and leaders in the field of Hepatology. The conference covers ongoing research in a variety of liver related topics which will potentially have significant impact on the future practice of Clinical Hepatology. The attendees will hear from and interact with the academic leaders who are actively contributing to these advances.
This 1-1/2 day course will offer didactic lectures in 6 topic areas relevant to mid-level hepatology professionals. Two breakout sessions titled Preventative Health Strategies in Cirrhosis and Prevention of Re-Hospitalizations in Patients with Decompensated Cirrhosis will feature small, interactive discussions with session organizers and networking opportunities with other attendees.
Upon completion of this activity, learners will be able to:
This activity was planned in the context of the following ACGME/IOM/IPEC competencies: Patient-centered Care, Work in Interdisciplinary Teams, Evidence-based Practice, Quality Improvement, Practice Based Learning and Improvement, Cognitive Expertise, Patient Care and Medical Knowledge.
Any support by grants for this activity will be disclosed in the program syllabus.